Illumina Reports 55-Percent Gain in Q4 Revenue as R&D Spending Surges and Profit Slides | GenomeWeb

NEW YORK, Feb. 2 (GenomeWeb News) - Illumina yesterday reported that fourth-quarter revenue increased 55 percent amid a sharp increase in R&D spending and a decline in profits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.